In contrast, GLS1 gene silencing in Gln‐dependent SKOV3ip1 tumor‐bearing animals showed significant reduction in both tumor weight (60%; P = 0.007) and tumor volume (75%; P = 0.008) when compared to control siRNA‐DOPC treated groups. The gene discussed is GLS; the disease is neoplasm.